Top

Clinical Oral Investigations

Published in:

01-01-2017 | Original Article

Short-term changes on C-reactive protein (CRP) levels after non-surgical periodontal treatment in systemically healthy individuals

Authors: André Barbisan de Souza, Rogério T. P. Okawa, Cléverson O. Silva, Maurício G. Araújo

Published in: Clinical Oral Investigations | Issue 1/2017

Abstract

Objectives

The aim of the present study was to evaluate serum C-reactive protein (CRP) levels in chronic periodontitis patients and periodontally healthy individuals and to assess the effect of non-surgical periodontal treatment on the CRP levels.

Materials and methods

Twenty-two patients with chronic periodontitis (test group) and 22 periodontally healthy individuals (control group), both groups without any systemic disorder or potential confounding factors, were included in the study. At baseline, periodontal clinical variables and CRP levels were obtained in both groups. In the test group, oral hygiene instruction and scaling and root planning were carried out; then, after 60 days, periodontal clinical variables and CRP levels were reevaluated.

Results

The baseline CRP level in the test group was significantly higher than the corresponding value in the control group (1.98 ± 1.55 vs. 1.26 ± 1.05 mg/L; p < 0.05). After periodontal treatment in the test group, there were improvements in all periodontal clinical variables (p < 0.05). The CRP level decreased significantly in those patients with higher baseline levels of CRP (>3 mg/L).

Conclusions

Chronic periodontitis seemed to promote elevated levels of CRP. Furthermore, non-surgical periodontal treatment significantly decreased the levels of CRP only in patients with high baseline levels of such pro-inflammatory cytokine.

Clinical relevance

Periodontitis may be a potential factor to change the risk of CVD. Thus, the control of periodontal infection performed by health professionals may improve cardiovascular health.

Vettore MV (2004) Periodontal disease and cardiovascular disease. Evid-based Dent 5:69CrossRefPubMed

Khader YS, Albashaireh ZS, Alomari MA (2004) Periodontal diseases and the risk of coronary heart and cerebrovascular diseases: a meta-analysis. J Periodontol 75:1046–1053CrossRefPubMed

Buhlin K, Mäntyla P, Paju S, Peltola JS, Nieminen MS, Sinisalo J, Pussinen PJ (2011) Periodontitis is associated with angiographically verified coronary artery disease. J Clin Periodontol 38:1007–1014CrossRefPubMed

Haro A, Saxlin T, Suominen A-L, Ylöstalo P, Leiviskä J, Tervonen T, Knuuttila M (2012) Serum lipids modify periodontal infection—C-reactive protein association. J Clin Periodontol:1–7

Goyal L, Bey A, Gupta ND, Sharma VK (2014) Comparative evaluation of serum C-reactive protein levels in chronic and aggressive periodontitis patients and association with periodontal disease severity. Contemp Clin Dent 5(4):484–488CrossRefPubMedPubMedCentral

Ardila CM, Guzmán IC (2015) Comparison of serum amyloid A protein and C-reactive protein levels as inflammatory markers in periodontitis. J Periodontal Implant Sci 45:14–22CrossRefPubMedPubMedCentral

Beck JD, Slade G, Offenbacher S (2000) Oral disease, cardiovascular disease and systemic inflammation. Perio 2000(23):110–120CrossRef

Schenkein HA, Loos BG (2013) Inflammatory mechanisms linking periodontal diseases to cardiovascular diseases. J Clin Periodontol 40(Suppl. 14):S51–S69PubMedPubMedCentral

Offenbacher S, Barros SP, Beck JD (2008) Rethinking periodontal inflammation. J Periodontol 79:1577–1584CrossRefPubMed

10.

Slade GD, Offenbacher S, Beck JD, Heiss G, Pankow JS (2000) Acutephase inflammatory response to periodontal disease in the US population. J Dent Res 79:49–57CrossRefPubMed

11.

Amar S, Gokce N, Morgan S, Loukideli M, Van Dyke TE, Vita JA (2003) Periodontal disease is associated with brachial artery endothelial dysfunction and systemic inflammation. Arter Thromb Vasc Biol 23:1245–1249CrossRef

12.

Teles R, Wang CY (2011) Mechanisms involved in the association between periodontal diseases and cardiovascular disease. Oral Dis 17:450–461CrossRefPubMedPubMedCentral

13.

Ridker PM, Glynn RJ, Hennekens CH (1998a) C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. Circulation 97:2007–2011CrossRefPubMed

14.

Ridker PM, Rifai N, Pfeffer MA, Sacks FM, Moye LA, Goldman S, Flaker GC, Braunwald E (1998b) Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Circulation 98:839–844CrossRefPubMed

15.

Blake GJ, Ridker PM (2001) High sensitivity C-reactive protein for predicting cardiovascular disease: an inflammatory hypothesis. Eur Heart J 22:349–352CrossRefPubMed

16.

Blake GJ, Rifai N, Buring JE, Ridker PM (2003) Blood pressure, C-reactive protein, and risk of future cardiovascular events. Circulation 108:2993–2999CrossRefPubMed

17.

Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH (1997) Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 336:973–979CrossRefPubMed

18.

Ridker PM, Hennekens CH, Buring JE, Rifai N (2000) C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342:836–843CrossRefPubMed

19.

De Backer G, Ambrosioni E, Borch-Johnsen K, Brotons C, Cifkova R, Dallongeville J, Ebrahim S, Faergeman O, Graham I, Mancia G, Manger Cats V, Orth-Gomér K, Perk J, Pyorälä K, Rodicio JL, Sans S, Sansoy V, Sechtem U, Silber S, Thomsene T, Wood D (2003) European guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J 24:1601–1610CrossRefPubMed

20.

Ridker PM, Danielson E, Fonseca FA, Genest J, AM G Jr, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, MacFadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ, JUPITER Study Group (2008) Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 359:2195–2207CrossRefPubMed

21.

Loos BG, Craandijk J, Hoek FJ, Wertheim-van Dillen PM, van der Velden U (2000) Elevation of systemic markers related to cardiovascular diseases in the peripheral blood of periodontitis patients. J Periodontol 71:1528–1534CrossRefPubMed

22.

Noack B, Genco RJ, Trevisan M, Grossi S, Zambon JJ, De Nardin E (2001) Periodontal infections contribute to elevated systemic C-reactive protein level. J Periodontol 72:1221–1227CrossRefPubMed

23.

Buhlin K, Gustafsson A, Pockley AG, Frostegard J, Klinge B (2003) Risk factors for cardiovascular disease in patients with periodontitis. Eur Heart J 24:2099–2107CrossRefPubMed

24.

Gorska R, Nedzi-Gora M (2006) The effects of the initial treatment phase and of adjunctive low-dose doxycycline therapy on clinical parameters and MMP-8, MMP-9, and TIMP-1 levels in the saliva and peripheral blood of patients with chronic periodontitis. Arch Immunol Ther Exp 54:419–426CrossRef

25.

Paraskevas S, Huizinga JD, Loos BG (2008) A systematic review and Meta-analyses on C-reactive protein in relation to periodontitis. J Clin Periodontol 35:277–290CrossRefPubMed

26.

D’Aiuto F, Orlandi M, Gunsolley JC (2013) Evidence that periodontal treatment improves biomarkers and CVD outcomes. J Clin Periodontol 40(Suppl. 14):S85–S105PubMed

27.

Mansia G, De Backer G, Dominiczak A, Cifkova R, Fagardi R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Struijker-Boudier HA, Zanchetti A (2007) Guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC). Euro Heart J 28:1462–1536

28.

World Health Organization (WHO) (2000) Obesity: Preventing and Managing the Global Epidemic. report of a WHO consultation. WHO Tech Rep Series 894:1–253

29.

Alberti KGMM, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart J-C, James WPT, Loria CM, Smith SC Jr (2009) Harmonizing the metabolic syndrome: a joint interim statement of the International diabetes Federation Task Force on Epidemiology and prevention; National Heart, Lung, and Blood Institute; American Heart Association; World heart Federation; International Atherosclerosis Society; and International Association for the Study of obesity. Circulation 120:1640–1645

30.

American Diabetes Association (2012) Executive summary: standards of medical care in diabetes - 2012. Diabetes Care 35:S4–S10CrossRef

31.

Wilson PWF, D’Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB (1998) Prediction of coronary heart disease using risk factor categories. Circulation 97:1837–1847CrossRefPubMed

32.

Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO III, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL, Rifai N, Smith SC Jr, Taubert K, Tracy RP, Vinicor F (2003) Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107:499–511CrossRefPubMed

33.

Ainamo J, Bay I (1975) Problems and proposals for recording gingivitis and plaque. Int Dent J 25:229–235PubMed

34.

O’leary TJ, Drake RB, Naylor JE (1972) The plaque control record. J Periodontol 43:38CrossRefPubMed

35.

Fredriksson MI, Figueredo CM, Gustafsson A, Bergstrom KG, Asman BE (1999) Effect of periodontitis and smoking on blood leukocytes and acute-phase proteins. J Periodontol 70:1355–1360CrossRefPubMed

36.

Craig RG, Yip JK, So MK, Boylan RJ, Socransky SS, Haffajee AD (2003) Relationship of destructive periodontal disease to the acute-phase response. J Periodontol 74:1007–1016CrossRefPubMed

37.

Joshipura KJ, Wand HC, Merchant AT, Rimm EB (2004) Periodontal disease and biomarkers related to cardiovascular disease. J Dent Res 83:151–155CrossRefPubMed

38.

Loos BG (2005) Systemic markers of inflammation in periodontitis. J Periodontol 76:2106–2115CrossRefPubMed

39.

Salzberg TN, Overstreet BT, Rogers JD, Califano JV, Best AM, Schenkein HA (2006) C-reactive protein levels in patients with aggressive periodontitis. J Periodontol 77:933–939CrossRefPubMed

40.

Gomes-Filho IS, Freitas Coelho JM, da Cruz SS, Passos JS, Teixeira de Freitas CO, Aragao Farias NS, Amorim da Silva R, Silva Pereira MN, Lima TL, Barreto ML (2011) Chronic periodontitis and C-reactive protein levels. J Periodontol 82:969–978CrossRefPubMed

41.

Pejcic A, Kesic LJ, Milasin J (2011) C-reactive protein as a systemic marker of inflammation in periodontitis. Eur J Clin Microbiol Infect Dis 30:407–414CrossRefPubMed

42.

Yamazaki K, Honda T, Oda T, Ueki-Maruyama K, Nakajima T, Yoshie H, Seymour GJ (2005) Effect of periodontal treatment on the C-reactive protein and proinflammatory cytokine levels in Japanese periodontitis patients. J Period Res 40:53–58CrossRef

43.

Wu JT, Wu LL (2006) Linking inflammation and atherogenesis: Soluble markers identified for the detection of risk factors and for early risk assessment. Clin Chim Acta 366:74–80CrossRefPubMed

44.

Hussain Bokhari SA, Khan AA, Tatakis DN, Azhar M, Hanif M, Izhar M (2009) Non-surgical periodontal therapy lowers serum inflammatory markers: a pilot study. J Periodontol 80:1574–1580CrossRefPubMed

45.

Vidal F, Figueredo CM, Cordovil I, Fischer RG (2009) Periodontal therapy reduces plasma levels of interleukin-6, C-reac- tive protein, and fibrinogen in patients with severe periodontitis and refractory arterial hypertension. J Periodontol 80:786–791CrossRefPubMed

46.

Correa FO, Goncalves D, Figueredo CM, Bastos AS, Gustafsson A, Orrico SR (2010) Effect of periodontal treatment on metabolic control, systemic inflammation and cytokines in patients with type 2 diabetes. J Clin Periodontol 37:53–58CrossRefPubMed

47.

Taylor B, Tofler G, Morel-Kopp MC, Carey H, Carter T, Elliott M, Dailey C, Villata L, Ward C, Woodward M, Schenck K (2010) The effect of initial treat- ment of periodontitis on systemic markers of inflammation and cardiovascular risk: a ran- domized controlled trial. Eur J Oral Sci 118:350–356CrossRefPubMed

48.

Tabet F, Rye KA (2009) High-density lipoproteins, inflammation and oxidative stress. Clin Sci (Lond) 116:87–98CrossRef

49.

Seinost G, Wimmer G, Skerget M, Thaller E, Brodmann M, Gasser R, Bratschko RO, Pilger E (2005) Periodontal treatment improves endothelial dysfunction in patients with severe periodontitis. Am Heart J 149:1050–1054CrossRefPubMed

50.

Marcaccini AM, Meschiari CA, Sorgi CA, Saraiva MCP, Souza AM, Faccioli LH, Tanus-Santos JE, Novaes AB Jr, Gerlach RF (2009) Circulating interleukin-6 and high-sensitivity C-reactive protein decrease after periodontal therapy in otherwise healthy subjects. J Periodontol 80:594–602CrossRefPubMed

51.

D’Aiuto F, Parkar M, Tonetti MS (2005) Periodontal therapy: a novel acute inflammatory model. Inflam Res 54:412–414CrossRef

52.

Mattila K, Vesanen M, Valtonen V, Nieminen M, Palosuo T, Rasi V, Asikainen S (2002) Effect of treating periodontitis on C-reactive protein levels: a pilot study. BMC Infect Dis 2:30CrossRefPubMedPubMedCentral

Title: Short-term changes on C-reactive protein (CRP) levels after non-surgical periodontal treatment in systemically healthy individuals
Authors: André Barbisan de Souza
Rogério T. P. Okawa
Cléverson O. Silva
Maurício G. Araújo
Publication date: 01-01-2017
Publisher: Springer Berlin Heidelberg
Published in: Clinical Oral Investigations / Issue 1/2017
Print ISSN: 1432-6981
Electronic ISSN: 1436-3771
DOI: https://doi.org/10.1007/s00784-016-1817-0

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Short-term changes on C-reactive protein (CRP) levels after non-surgical periodontal treatment in systemically healthy individuals

Abstract

Objectives

Materials and methods

Results

Conclusions

Clinical relevance

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Objectives

Materials and methods

Results

Conclusions

Clinical relevance

Please log in to get access to this content

Other articles of this Issue 1/2017

Novel FGF10 mutation in autosomal dominant aplasia of lacrimal and salivary glands

Effect of hyperbaric oxygen therapy on tooth extraction sites in rats subjected to bisphosphonate therapy—histomorphometric and immunohistochemical analysis

Triptolide represses oral cancer cell proliferation, invasion, migration, and angiogenesis in co-inoculation with U937 cells

Normoxic accumulation of HIF1α is associated with glutaminolysis

Anatomical relationship between mental foramen, mandibular teeth and risk of nerve injury with endodontic treatment

The effect of different collagen modifications for titanium and titanium nitrite surfaces on functions of gingival fibroblasts